Interaction of chondroitin sulfate and dermatan sulfate from various biological sources with heparin-binding growth factors and cytokines

被引:71
|
作者
Mizumoto, Shuji [1 ]
Fongmoon, Duriya [1 ]
Sugahara, Kazuyuki [1 ]
机构
[1] Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Frontier Res Ctr Postgenom Sci & Technol,Kita Ku, Sapporo, Hokkaido 0010021, Japan
基金
日本学术振兴会;
关键词
Chondroitin sulfate; Dermatan sulfate; Growth factors; Cytokines; Interaction analysis; Surface plasmon resonance; EMBRYONIC PIG BRAIN; HYBRID CHAINS; KNEE OSTEOARTHRITIS; PROTEIN INTERACTIONS; IN-VIVO; GLYCOSAMINOGLYCANS; CELLS; CHEMOKINE; RANTES; ACID;
D O I
10.1007/s10719-012-9463-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chondroitin sulfate (CS) and dermatan sulfate (DS) interact with various extracellular molecules such as growth factors, cytokines/chemokines, neurotrophic factors, morphogens, and viral proteins, thereby playing roles in a variety of biological processes including cell adhesion, proliferation, tissue morphogenesis, neurite outgrowth, infections, and inflammation/leukocyte trafficking. CS/DS are modified with sulfate groups at C-2 of uronic acid residues as well as C-4 and/or C-6 of N-acetyl-D-galactosamine residues, yielding enormous structural diversity, which enables the binding with numerous proteins. We have demonstrated that highly sulfated CS-E from squid cartilage, for example, interacts with heparin-binding proteins including midkine, pleiotrophin, and fibroblast growth factors expressed in brain with high affinity (Kd values in the nM range). Here, we analyzed the binding of CS and DS, which have a relatively low degree of sulfation and have been widely used as a nutraceutical and a drug for osteoarthritis etc., with a number of heparin-binding neurotrophic factors/cytokines using surface plasmon resonance (SPR) and structurally characterized the CS/DS chains. SPR showed that relatively low sulfated CS-A, DS, and CS-C also bound with significant affinity to midkine, pleiotrophin, hepatocyte growth factor, monokine-induced by interferon-gamma, and stromal cell derived factor-1 beta, although the binding was less intense than that with highly sulfated CS-D and CS-E. These findings suggest that even low sulfated CS and/or DS chains may contain binding domains, which include fine sugar sequences with specific sulfation patterns, and that sugar sequences, conformations and electrostatic potential are more important than the simple degree of sulfation represented by disaccharide composition.
引用
收藏
页码:619 / 632
页数:14
相关论文
共 50 条
  • [31] Interaction of heparin and heparin-derived oligosaccharides with synthetic peptide analogues of the heparin-binding domain of heparin/heparan sulfate-interacting protein
    Wang, Jing
    Rabenstein, Dallas L.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2009, 1790 (12): : 1689 - 1697
  • [32] Intraarticular Injection of Heparin-Binding Insulin-like Growth Factor 1 Sustains Delivery of Insulin-like Growth Factor 1 to Cartilage Through Binding to Chondroitin Sulfate
    Miller, Rachel E.
    Grodzinsky, Alan J.
    Cummings, Kiersten
    Plaas, Anna H. K.
    Cole, Ada A.
    Lee, Richard T.
    Patwari, Parth
    ARTHRITIS AND RHEUMATISM, 2010, 62 (12): : 3686 - 3694
  • [33] The biological activity of HB-EGF is modulated by its heparin-binding domain and by association with heparan sulfate proteoglycans
    Takazaki, Risa
    Iwamoto, Ryo
    Mekada, Eisuke
    CELL STRUCTURE AND FUNCTION, 2004, 29 : 76 - 76
  • [34] A simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin/dermatan sulfates from biological samples
    Deakin, Jon A.
    Lyon, Malcolm
    GLYCOBIOLOGY, 2008, 18 (06) : 483 - 491
  • [35] A novel structural fucosylated chondroitin sulfate from Holothuria Mexicana and its effects on growth factors binding and anticoagulation
    Li, Qinying
    Cai, Chao
    Chang, Yaoguang
    Zhang, Fuming
    Linhardt, Robert J.
    Xue, Changhu
    Li, Guoyun
    Yu, Guangli
    CARBOHYDRATE POLYMERS, 2018, 181 : 1160 - 1168
  • [36] Heparan sulfate modifying enzymes deliver cancer, stromal and macrophage-produced heparin-binding growth factors in the prostate cancer microenvironment
    Brasil, Fabio H.
    Ferrer, Valeria
    Navone, Nora M.
    Farach-Carson, Mary C.
    Carson, Daniel D.
    CANCER RESEARCH, 2016, 76
  • [37] Engineering of a heparin-binding fibroblast growth factor with augmented activity and stability by fusion with heparan sulfate proteoglycan.
    Yoneda, A
    Asada, M
    Oda, Y
    Imamura, T
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 55A - 55A
  • [38] Heparan sulfate proteoglycans regulate the intracellular localization and processing of heparin binding growth factors
    Sperinde, GV
    Nugent, MA
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 235A - 235A
  • [39] Heparin-binding and oligomerization of hepatocyte growth factor/scatter factor isoforms; Heparan sulfate glycosaminoglycan requirement for Met binding and signaling
    Sakata, H
    Stahl, SJ
    Taylor, WG
    Rosenberg, JM
    Sakaguchi, K
    Wingfield, PT
    Rubin, JS
    FASEB JOURNAL, 1997, 11 (09): : A924 - A924
  • [40] PURIFICATION AND CHARACTERIZATION OF HEPARIN-BINDING GROWTH-FACTORS FROM PORCINE UTERUS
    BRIGSTOCK, DR
    HEAP, RB
    BARKER, PJ
    BROWN, KD
    BIOCHEMICAL JOURNAL, 1990, 266 (01) : 273 - 282